Atlas Trials

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Clinical trial NCT00126802 · UNKNOWN

Trial details

NCT number
NCT00126802
Sponsor
AHS Cancer Control Alberta
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2005-04-01
Primary completion
2017-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.